pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
Final Assay Results Confirm High-Grade, Near-Surface Fluorspar and Gallium Mineralisation at Monte Muambe
